News

Bio-plastics startup wins Lighthouse Labs pitch contest

Charlottsville, VA (Virginia Business) – While pitching to the sharks, entrepreneur Alec Brewer told them, “I do have white powder in my pocket,” before quickly clarifying that it wasn’t an illicit substance: “It’s PHB! It’s PHB!”

The co-founder and CEO of Charlottesville-based biodegradable plastics manufacturer Ourobio, Brewer explained that his company makes PHB, or polyhydroxybutyrate, from waste in order to reduce microplastics pollution. Ourobio converts whey into PHB through a biochemical process.

Ourobio was voted “shark favorite” out of nine entrepreneurs in Richmond business accelerator Lighthouse Labs’ 2022 spring cohort that pitched to four business leaders as part of the accelerator’s biannual Demo Day competition May 24. Ourobio received $1,500 from sponsor ThinkNimble and will have naming rights to a tagged great white shark that Lighthouse Labs is sponsoring.

Founded in 2012, Lighthouse Labs is a mentor-driven nonprofit accelerator that runs two, 12-week cohort sessions each year, investing $20,000 equity-free in six to 10 early-stage startups. Entrepreneurs accepted into the program receive mentorship and education on scaling up their businesses. Lighthouse Labs has accelerated more than 80 companies during the last 10 years, providing more than $1.6 million in equity-free funding. The Demo Day pitch contest is the grand finale event for each cohort.

Llamawood CEO Hunter Garen won the audience vote in the Demo Day competition; for his prize, he was given the privilege of throwing the first pitch at a Richmond Flying Squirrels baseball game.

While the same may not be true for his throwing arm,  Garen started his business pitch with a flourish, tossing postcards with coupon codes into the first few rows. Llamawood connects firewood suppliers and purchasers.

“I designed for a woman … because, as they say, women’s standards are much higher than men’s, so if you design for a woman, you’ll make every man happy,” Garen joked when telling the sharks about his customer demographics.

Sharks judging the competition were: Ajay Kori of UrbanStems and Novilla Pharmaceuticals; Claire Herring of Blue Ocean Brain; Richard Wintsch of Startup Virginia; and Joy Polefrone with VCU Health.

Also pitching at the competition were founders of Richmond-based beauty company LipLoveLine; Philadelphia-based software manufacturer Viora Health; Fort Belvoir-based health tech company Kinometrix Inc.; Philadelphia-based health care tech firm Hoth Intelligence; Richmond-based Nessle, which operates an online platform for expectant  parents; Austin, Texas-based tech firm On-Time Trials; and Houston-based health care tech company CaseCTRL.

Read more here.

Recent News

04/24/2026

Skyphos Technologies Has Been Awarded its Second U.S. Patent

Skyphos Technologies has been awarded its second U.S. patent, adding to a growing intellectual property portfolio that now includes nearly a dozen patent applications in process around the world. This latest patent secures core technologies and methods that allow micro-scale parts to be produced in seconds, at throughputs designed to exceed legacy manufacturing such as

04/23/2026

CollectiveMinds LLC Places Keith Meadors as Chief Commercial Officer at Genova Diagnostics

CollectiveMinds LLC, a leading executive search firm specializing in life sciences and healthcare, today announced the successful placement of Keith Meadors as Chief Commercial Officer of Genova Diagnostics, a pioneer in advanced diagnostic testing. The appointment marks another milestone for CollectiveMinds in connecting exceptional leadership talent with high-growth organizations across the diagnostics and life sciences

04/22/2026

RIVANNA expands multi-site clinical study for Accuro XV musculoskeletal imaging system

RIVANNA®, developer of AI-enabled clinical decision-support solutions, announced that it has expanded its clinical studies evaluating Accuro® XV, the company’s musculoskeletal imaging system, from two to eight sites nationwide. This expansion follows execution of a funding option by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response